mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.2 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.068 |
0.2 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |